Shandong Xinhua Pharmaceutical Company Limited

SEHK:719 株式レポート

時価総額：HK$9.5b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Shandong Xinhua Pharmaceutical マネジメント

マネジメント 基準チェック /34

Shandong Xinhua Pharmaceutical'sの CEO はWenhui Xuで、 Sep2022年に任命され、 の在任期間は 1.75年です。 の年間総報酬はCN¥ 1.52Mで、 93.8%給与と6.2%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.035%を直接所有しており、その価値はHK$ 3.25M 。経営陣と取締役会の平均在任期間はそれぞれ4.5年と3.5年です。

主要情報

Wenhui Xu

最高経営責任者

CN¥1.5m

報酬総額

CEO給与比率93.8%
CEO在任期間2yrs
CEOの所有権0.04%
経営陣の平均在職期間4.8yrs
取締役会の平均在任期間3.8yrs

経営陣の近況

Recent updates

Shandong Xinhua Pharmaceutical (HKG:719) Is Paying Out A Larger Dividend Than Last Year

Jun 28
Shandong Xinhua Pharmaceutical (HKG:719) Is Paying Out A Larger Dividend Than Last Year

Insufficient Growth At Shandong Xinhua Pharmaceutical Company Limited (HKG:719) Hampers Share Price

Jan 23
Insufficient Growth At Shandong Xinhua Pharmaceutical Company Limited (HKG:719) Hampers Share Price

Shandong Xinhua Pharmaceutical (HKG:719) Takes On Some Risk With Its Use Of Debt

Mar 07
Shandong Xinhua Pharmaceutical (HKG:719) Takes On Some Risk With Its Use Of Debt

Is Shandong Xinhua Pharmaceutical (HKG:719) Using Too Much Debt?

Nov 18
Is Shandong Xinhua Pharmaceutical (HKG:719) Using Too Much Debt?

These 4 Measures Indicate That Shandong Xinhua Pharmaceutical (HKG:719) Is Using Debt Extensively

Jul 27
These 4 Measures Indicate That Shandong Xinhua Pharmaceutical (HKG:719) Is Using Debt Extensively

Shandong Xinhua Pharmaceutical (HKG:719) Has Affirmed Its Dividend Of HK$0.18

Jul 04
Shandong Xinhua Pharmaceutical (HKG:719) Has Affirmed Its Dividend Of HK$0.18

Estimating The Intrinsic Value Of Shandong Xinhua Pharmaceutical Company Limited (HKG:719)

Mar 09
Estimating The Intrinsic Value Of Shandong Xinhua Pharmaceutical Company Limited (HKG:719)

We Think Shandong Xinhua Pharmaceutical (HKG:719) Can Stay On Top Of Its Debt

Dec 21
We Think Shandong Xinhua Pharmaceutical (HKG:719) Can Stay On Top Of Its Debt

Does Shandong Xinhua Pharmaceutical (HKG:719) Deserve A Spot On Your Watchlist?

Apr 06
Does Shandong Xinhua Pharmaceutical (HKG:719) Deserve A Spot On Your Watchlist?

What Kind Of Shareholders Own Shandong Xinhua Pharmaceutical Company Limited (HKG:719)?

Mar 19
What Kind Of Shareholders Own Shandong Xinhua Pharmaceutical Company Limited (HKG:719)?

Is Shandong Xinhua Pharmaceutical (HKG:719) A Risky Investment?

Feb 26
Is Shandong Xinhua Pharmaceutical (HKG:719) A Risky Investment?

Are Shandong Xinhua Pharmaceutical's (HKG:719) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 05
Are Shandong Xinhua Pharmaceutical's (HKG:719) Statutory Earnings A Good Guide To Its Underlying Profitability?

Shandong Xinhua Pharmaceutical (HKG:719) Share Prices Have Dropped 43% In The Last Three Years

Jan 18
Shandong Xinhua Pharmaceutical (HKG:719) Share Prices Have Dropped 43% In The Last Three Years

Is Shandong Xinhua Pharmaceutical Company Limited (HKG:719) A Smart Pick For Income Investors?

Dec 29
Is Shandong Xinhua Pharmaceutical Company Limited (HKG:719) A Smart Pick For Income Investors?

Do Institutions Own Shandong Xinhua Pharmaceutical Company Limited (HKG:719) Shares?

Dec 14
Do Institutions Own Shandong Xinhua Pharmaceutical Company Limited (HKG:719) Shares?

Is Shandong Xinhua Pharmaceutical (HKG:719) Using Too Much Debt?

Nov 26
Is Shandong Xinhua Pharmaceutical (HKG:719) Using Too Much Debt?

CEO報酬分析

Shandong Xinhua Pharmaceutical の収益と比較して、Wenhui Xu の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

CN¥492m

Mar 31 2024n/an/a

CN¥487m

Dec 31 2023CN¥2mCN¥1m

CN¥497m

Sep 30 2023n/an/a

CN¥510m

Jun 30 2023n/an/a

CN¥486m

Mar 31 2023n/an/a

CN¥454m

Jan 01 2023n/an/a

CN¥411m

Sep 30 2022n/an/a

CN¥357m

Jun 30 2022n/an/a

CN¥343m

Mar 31 2022n/an/a

CN¥357m

Dec 31 2021CN¥1mn/a

CN¥349m

Sep 30 2021n/an/a

CN¥364m

Jun 30 2021n/an/a

CN¥353m

Mar 31 2021n/an/a

CN¥339m

Dec 31 2020CN¥829kn/a

CN¥325m

報酬と市場: Wenhuiの 総報酬 ($USD 209.82K ) は、 Hong Kong市場 ($USD 477.16K ) の同様の規模の企業の平均を下回っています。

報酬と収益: Wenhuiの報酬は過去 1 年間で 20% 以上増加しました。

CEO（最高経営責任者

Wenhui Xu (47 yo)

2yrs

在職期間

CN¥1,521,382

報酬

Mr. Wenhui Xu serves as Executive Director and General Manager of Shandong Xinhua Pharmaceutical Company Limited since October 27, 2022 and September 19, 2022 respectively. He served as the Deputy General...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Tongqing He
Chairman & Deputy GM3.8yrsCN¥1.61m0.043%
CN¥ 4.1m
Wenhui Xu
GM & Executive Director2yrsCN¥1.52m0.035%
CN¥ 3.4m
Ning Hou
CFO, Financial Controller & Executive Director10.4yrsCN¥1.28m0.048%
CN¥ 4.6m
Zhonghui Zheng
Deputy General Manager7.5yrsCN¥1.41m0.043%
CN¥ 4.1m
Changsheng Wei
Deputy GM & Manager of Administrative Personnel Departmentno dataCN¥1.41m0.035%
CN¥ 3.4m
Xuesong Liu
Deputy General Manager2yrsCN¥831.80k0.013%
CN¥ 1.3m
Changqiu Cao
Company Secretary27.2yrsCN¥446.80k0.029%
CN¥ 2.8m
Zuxing Kou
Deputy General Manager2yrsCN¥1.10m0.011%
CN¥ 1.0m
Haifeng Guo
Head of Accounting Departmentno dataデータなしデータなし
Xiaohong He
Chief of Finance Departmentno dataデータなしデータなし

4.8yrs

平均在職期間

51yo

平均年齢

経験豊富な経営陣: 719の経営陣は 経験豊富 であると考えられます ( 4.5年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Tongqing He
Chairman & Deputy GM3.8yrsCN¥1.61m0.043%
CN¥ 4.1m
Wenhui Xu
GM & Executive Director1.9yrsCN¥1.52m0.035%
CN¥ 3.4m
Ning Hou
CFO, Financial Controller & Executive Director1.9yrsCN¥1.28m0.048%
CN¥ 4.6m
Zhichao Tao
Independent Supervisor22.3yrsCN¥24.00kデータなし
Lie Xu
Non-Executive Director14.3yrsCN¥1.41m0.043%
CN¥ 4.1m
Yanhua Hu
Employee Supervisor13.2yrsCN¥101.00kデータなし
Guangcheng Pan
Independent Non-Executive Director3.8yrsCN¥100.00kデータなし
Chengtong Liu
Chairman of Supervisory Committee3.8yrsデータなしデータなし
Jianwei Zhu
Independent Non-Executive Director3.8yrsCN¥100.00kデータなし
Peixue Ling
Independent Non-Executive Director1.9yrsCN¥58.33kデータなし
Chengyong Zhang
Non-Independent Directorless than a yearデータなしデータなし
Ching Ching Cheung
Independent Non-Executive Directorless than a yearデータなしデータなし

3.8yrs

平均在職期間

54yo

平均年齢

経験豊富なボード: 719の 取締役会 は 経験豊富 であると考えられます ( 3.5年の平均在任期間)。